Targeted therapies: Front-line therapy in lung cancer with mutations in EGFR

Nat Rev Clin Oncol. 2011 Aug 30;8(10):571-3. doi: 10.1038/nrclinonc.2011.135.
No abstract available

Publication types

  • News

MeSH terms

  • ErbB Receptors / genetics*
  • Humans
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / therapy*
  • Molecular Targeted Therapy*
  • Mutation / genetics*

Substances

  • EGFR protein, human
  • ErbB Receptors